Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children.

NCT00743652 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

373

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Disease
13-valent Pneumococcal Vaccine

Interventions

BIOLOGICAL: 13-valent Pneumococcal Conjugate Vaccine
BIOLOGICAL: 13-valent Pneumococcal Conjugate Vaccine
BIOLOGICAL: 13-valent Pneumococcal Conjugate Vaccine
BIOLOGICAL: 13-valent Pneumococcal Conjugate Vaccine
BIOLOGICAL: 13-valent Pneumococcal Conjugate Vaccine

Sponsor

Pfizer